| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 04/19/2007 | DE10248141B4 Nukleinsäuren und deren Verwendung für die Gentherapie Nucleic acids and their use for gene therapy |
| 04/19/2007 | CA2639119A1 Agent for preventing/treating cancer |
| 04/19/2007 | CA2627623A1 Methods for inhibiting protein kinases |
| 04/19/2007 | CA2626011A1 S1p3 receptor antagonist |
| 04/19/2007 | CA2625998A1 Optimized anti-cd30 antibodies |
| 04/19/2007 | CA2625741A1 Treating renal cancer using 4-[bis[2-[(methylsulfonyl)oxy]ethyl]amino]-2-methyl-benzaldehyde |
| 04/19/2007 | CA2625681A1 Generation and profiling of fully human hucal gold-derived therapeutic antibodies specific for human cd38 |
| 04/19/2007 | CA2625440A1 Compositions comprising cross-species-specific antibodies and uses thereof |
| 04/19/2007 | CA2625436A1 Selective alfavbeta3 receptor peptide antagonist for therapeutic and diagnostic applications |
| 04/19/2007 | CA2625219A1 Heterocyclic compounds as pstat3/il-6 inhibitors |
| 04/19/2007 | CA2625042A1 Iontophoretic preparation for treatment of breast cancer and/or mastitis |
| 04/19/2007 | CA2624965A1 Pyridopyrimidinone inhibitors of pi3k.alpha. |
| 04/19/2007 | CA2624958A1 Antimitotic rhizoxin derivatives of burkholderia rhizoxina, method for producing said derivatives and use thereof |
| 04/19/2007 | CA2624902A1 Novel pyrazolopyrimidines as cyclin dependent kinase inhibitors |
| 04/19/2007 | CA2624829A1 Novel pyrazolopyrimidines as cyclin dependent kinase inhibitors |
| 04/19/2007 | CA2624826A1 Pyrazolopyrimidines as protein kinase inhibitors |
| 04/19/2007 | CA2624822A1 Pyrazolopyrimidines as cyclin dependent kinase inhibitors for the treatment of cancer |
| 04/19/2007 | CA2624781A1 Nanobodies tm and polypeptides against egfr and igf-ir |
| 04/19/2007 | CA2624683A1 Modulators of atp-binding cassette transporters |
| 04/19/2007 | CA2624610A1 Kinase inhibitors |
| 04/19/2007 | CA2624519A1 Pyrazolo [1,5-a] pyrimidines as protein kinase inhibitors |
| 04/19/2007 | CA2624500A1 Pyrazolopyrimidines as protein kinase inhibitors |
| 04/19/2007 | CA2624025A1 Regimen of administration for 5-(2-chlorophenyl)-1 ,2-dihydro-7-fluoro-8-methoxy-3-methyl-pyrazolo [3, 4.-b] [1, 4] benzodiazepine |
| 04/19/2007 | CA2623770A1 Pyridopyrimidinone inhibitors of pi3k.alpha. |
| 04/19/2007 | CA2623768A1 N- (3-amino-quinoxalin-2-yl) -sulfonamide derivatives and their use as phosphatidylinositol 3-kinase inhibitors |
| 04/19/2007 | CA2623563A1 Method of inhibiting angiogenesis by using ephrin b2 |
| 04/19/2007 | CA2623327A1 Nitrogenated heterocyclic compound and pharmaceutical composition comprising the same |
| 04/19/2007 | CA2623109A1 Compositions and methods for treating proliferative disorders |
| 04/19/2007 | CA2622464A1 Use of liposomes in a carrier comprising a continuous hydrophobic phase as a vehicle for cancer treatment |
| 04/19/2007 | CA2620308A1 Crystalline forms of docetaxel and processes for their preparation |
| 04/18/2007 | EP1775343A1 Anticancer agent containing dendritic cell having rna virus transferred thereinto |
| 04/18/2007 | EP1775342A1 Anticancer agent containing minus-strand rna virus |
| 04/18/2007 | EP1775307A2 Bispecific antibody effective to treat B-cell lymphoma and cell line |
| 04/18/2007 | EP1775300A1 Process for production of polysubstituted cyclobutanes and polysubstituted cyclobutenes |
| 04/18/2007 | EP1775289A1 Novel imidazolidine derivatives |
| 04/18/2007 | EP1774976A1 Malignant tumor local infiltration inhibitor containing batroxobin |
| 04/18/2007 | EP1774966A1 Inhibitor for the onset and progress of liver cancer to be used in hepatitis c virus-positive human liver cirrhosis patients |
| 04/18/2007 | EP1773988A2 Methods for inducing the differentiation of blood monocytes into functional dendritic cells |
| 04/18/2007 | EP1773885A2 Humanized anti-cmet antagonists |
| 04/18/2007 | EP1773884A2 Therapeutic and diagnostic methods and compositions targeting 4ig-b7-h3 and its counterpart nk cell receptor |
| 04/18/2007 | EP1773854A2 Azasugar derivatives, heparanase inhibitors, method for preparing same, compositions containing same, use thereof |
| 04/18/2007 | EP1773850A2 Prodrugs of hiv protease inhibitors |
| 04/18/2007 | EP1773837A2 Pyrrolotriazine kinase inhibitors |
| 04/18/2007 | EP1773836A1 Pyrrolopyrimidine derivatives useful in cancer treatment |
| 04/18/2007 | EP1773834A2 2, 8-disubstituted naphthyridine derivatives |
| 04/18/2007 | EP1773830A1 Fused pyrimidones useful in the treatment and the prevention of cancer |
| 04/18/2007 | EP1773824A1 2,4,6-trisubstituted pyrimidines as phosphotidylinositol (pi) 3-kinase inhibitors and their use in the treatment of cancer |
| 04/18/2007 | EP1773817A1 Substituted aryl-amine derivatives and methods of use |
| 04/18/2007 | EP1773815A2 Mitotic kinesin inhibitors |
| 04/18/2007 | EP1773813A1 Crystalline polymorph of pipindoxifene hydrochloride monohydrate |
| 04/18/2007 | EP1773791A1 Pyrrolotriazine compounds |
| 04/18/2007 | EP1773768A2 Pyrrole derivatives as pharmaceutical agents |
| 04/18/2007 | EP1773766A2 Iap binding compounds |
| 04/18/2007 | EP1773452A2 Lysis / resealing process and device for incorporating an active ingredient in erythrocytes |
| 04/18/2007 | EP1773451A2 Use of 7-t-butoxyiminomethylcamptothecin for treating uterine neoplasms |
| 04/18/2007 | EP1773406A2 Method for screening agents against human prostate disease |
| 04/18/2007 | EP1773402A2 Improved efficacy of immunotherapy by integrating diagnostic with therapeutic methods |
| 04/18/2007 | EP1773380A1 Hai-1 and hai-2 in cancer therapy |
| 04/18/2007 | EP1773375A1 Netrin-related compositions and uses |
| 04/18/2007 | EP1773348A2 Tetrapeptide analogs |
| 04/18/2007 | EP1773346A1 Substituted quinobenzoxazine analogs and methods of using thereof |
| 04/18/2007 | EP1773335A2 Nanoparticle dispersion containing lactam compound |
| 04/18/2007 | EP1773334A1 Epothilone combinations |
| 04/18/2007 | EP1773327A1 Inhibitors of hsp90 |
| 04/18/2007 | EP1773326A2 Mitotic kinesin inhibitors |
| 04/18/2007 | EP1773324A1 Porphyrin derivatives and their use in photon activation therapy |
| 04/18/2007 | EP1773318A1 Combination anticancer therapy and pharmaceutical compositions therefor |
| 04/18/2007 | EP1773309A1 Tamoxifen response in pre-and postmenopausal breast cancer patients |
| 04/18/2007 | EP1542989B1 Protein tyrosine kinase inhibitors |
| 04/18/2007 | EP1514115B1 Diagnostic agent, method for detecting a carcinoma, and means for the treatment thereof |
| 04/18/2007 | EP1480636B1 Self emulsifying drug delivery systems for taxoids |
| 04/18/2007 | EP1476438B1 Oxa- and thiadiazoles and their use as metalloproteinase inhibitors |
| 04/18/2007 | EP1458386B1 Aroyl pyrrole heteroeryl and methanols useful for treating a central nervous system disorder |
| 04/18/2007 | EP1442032B1 Heterocyclic retinoid compounds |
| 04/18/2007 | EP1439859B1 An antineoplastic- dendritic polymer drug delivery system |
| 04/18/2007 | EP1436257B1 Low-calcemic oxime analogs of 1alpha, 25-dihydroxy vitamin d3 |
| 04/18/2007 | EP1434877B1 Chromogenic in situ hybridization methods, kits, and compositions |
| 04/18/2007 | EP1401479B1 Detection and therapy of vulnerable plaque with photodynamic compounds |
| 04/18/2007 | EP1392313B1 Combination comprising n- 5- 4-(4-methyl-piperazino-methyl)-benzoylamido|-2-methylphenyl -4-(3-pyridyl)-2pyrimidine-amine and a biphosphonate |
| 04/18/2007 | EP1353673B1 Camptothecin derivatives |
| 04/18/2007 | EP1353662B1 Methods for the treatment of diseases using malonyl-coa decarbox ylase inhibitors |
| 04/18/2007 | EP1352063B1 Receptor nucleic acids and polypeptides |
| 04/18/2007 | EP1334194B1 Imaging, diagnosis and treatment of disease |
| 04/18/2007 | EP1313508B1 Combination containing an antifolate and methylmalonic acid lowering agent |
| 04/18/2007 | EP1307746B1 Identification of viral agents in breast ducts and antiviral therapy therefore |
| 04/18/2007 | EP1305030B1 Use of 2-alpha-methyl-19-nor-20(s)-1-alpha,25-dihydroxyvitamin d3 in bone replacement |
| 04/18/2007 | EP1276718B1 Small technetium-99m and rhenium labeled agents and methods for imaging tumors |
| 04/18/2007 | EP1248645B1 Novel chimeric proteins and their use |
| 04/18/2007 | EP1187846B1 11beta long-chain substituted estratrienes, method for their production, pharmaceutical preparations containing said 11beta long-chain substituted estratrienes, and their use for producing medicaments |
| 04/18/2007 | EP1153125B1 Deglycosylated kringle 1-5 region fragments of plasminogen and methods of use |
| 04/18/2007 | EP1135160B1 Boron neutron capture therapy using pre-targeting methods |
| 04/18/2007 | EP1024835B1 J-chain and analogues as epithelial cell targeting conjugates |
| 04/18/2007 | EP1012282B1 Cysteine rich receptors-train |
| 04/18/2007 | EP1007080B1 Formulation for the sustained release of peptide agonists and analogues of GnRH |
| 04/18/2007 | EP1005374B1 Microparticles for delivery of nucleic acid |
| 04/18/2007 | EP0960117B1 FIBROBLAST GROWTH FACTOR HOMOLOGOUS FACTORS (FHFs) AND METHODS OF USE |
| 04/18/2007 | EP0956865B1 MEDICINES COMPRISING Rho KINASE INHIBITOR |
| 04/18/2007 | CN1950521A Granulin-epithelin precursor (GEP) overexpression as a target for diagnosis, prognosis and treatment of hepatocellular carcinoma (HCC) |
| 04/18/2007 | CN1950399A Less immunogenic binding molecules |
| 04/18/2007 | CN1950377A Thienopyridines as IKK inhibitors |